Global Ewing Sarcoma Disease Clinical Trials Report, H1 2021 Review – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Ewing Sarcoma Disease – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering.

“Ewing Sarcoma Disease – Global Clinical Trials Review, H1, 2021” provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma.

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The publisher Clinical Trial Reports are generated using the publisher’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

Report Guidance

• Clinical Trials Report Coverage

Clinical Trials by Region

• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Countries Contributing to Clinical Trials in Middle East and Africa
• Top Five Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Ewing Sarcoma to Oncology Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Ewing Sarcoma to Oncology Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

• In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

• Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

• Prominent Sponsors
• Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials

Prominent Drugs

• Clinical Trial Profile Snapshots

Appendix

Companies Mentioned

• Bristol-Myers Squibb Co
• Eli Lilly and Co
• Merck & Co Inc
• Pfizer Inc
• Bayer AG
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline Plc
• Gradalis Inc
• Novartis AG
• Pharma Mar SA

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/52zivb

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900